Inebilizumab
Product Specifications
CAS Number
1299440-37-1
Target
Immunology/Inflammation related|||ADC Antibody
Related Pathways
Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related
Purity
0.993
Bioactivity
Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
FAB3495MFV610 0.1 mL
Mouse Monoclonal LRIG3 Antibody (814834) [mFluor Violet 610 SE]
Ask
View Details